The FDA's Veterinary Medicine Advisory Committee will hold a meeting on Sept. 19 and 20 to evaluate scientific data and determine whether AquaBounty Technologies' biotech salmon should be approved for human consumption. The FDA also scheduled a public meeting for Sept. 21 to determine whether to label the product as being genetically modified.

Related Summaries